Related Experiment Videos
Epithelial alterations adjacent to 111 vulvar carcinomas.
G Borgno1, L Micheletti, M Barbero
1Institute of Gynecology and Obstetrics, University of Turin, Italy.
The Journal of Reproductive Medicine
|June 1, 1988
Summary
Histopathologic analysis of 111 vulvar carcinomas reveals that dystrophic lesions and carcinoma in situ (CIS) are frequently found adjacent to invasive vulvar cancer. These findings highlight common precursor lesions in vulvar cancer development.
Area of Science:
- Gynecologic Pathology
- Oncology
- Dermatopathology
Background:
- Vulvar cancer is a significant gynecologic malignancy.
- Understanding the histopathologic changes adjacent to invasive vulvar carcinoma is crucial for identifying precursor lesions and improving patient outcomes.
Purpose of the Study:
- To investigate the spectrum of histopathologic changes in tissues adjacent to 111 cases of invasive primary vulvar carcinomas.
- To categorize and quantify these adjacent changes, including dystrophic lesions, carcinoma in situ (CIS), and human papillomavirus (HPV)-related changes.
Main Methods:
- Retrospective review of histopathologic material from 111 invasive primary vulvar carcinomas.
- Classification of adjacent tissue characteristics into predefined categories.
- Statistical analysis of the frequency of different adjacent histopathologic findings.
Main Results:
- Dystrophic lesions were observed adjacent to invasive vulvar cancer in 57.6% of cases.
- Carcinoma in situ (CIS) was found adjacent to invasive cancer in 21.6% of cases.
- Epithelial changes suggestive of human papillomavirus infection were present in 18.9% of cases, and no specific alterations were found in 40.5%.
Conclusions:
- Dystrophic lesions and CIS are common findings adjacent to invasive vulvar carcinomas, suggesting a potential role as precursor lesions.
- A spectrum of epithelial changes, from dystrophy to CIS, can be found adjacent to invasive vulvar cancer.
- Further research into the relationship between these adjacent changes and vulvar cancer development is warranted.